Newspaper article Pittsburgh Post-Gazette (Pittsburgh, PA)

Don't Let Up the Pressure on Congress about Drug Prices

Newspaper article Pittsburgh Post-Gazette (Pittsburgh, PA)

Don't Let Up the Pressure on Congress about Drug Prices

Article excerpt

Though we all remember the EpiPen pricing outrage from the summer, it seems that as the air has cooled, so has the public indignation. As the Nov. 17 article "Drug Prices Don't Budge Even After Public Pressure From Congress" shows, public outcry over pharmaceutical company pricing has so far resulted in little actual change.

When brought in front of Congress to testify, companies like Mylan tout their coupon programs, which do lower the price paid out- of-pocket for patients. However, this does not lower the prices paid by insurers. Though they do have some bargaining power, they are largely subservient to the drug companies.

Without regulation, drug prices can rise "as high as the market will bear." But the market for drugs differs from the market for other products. …

Search by... Author
Show... All Results Primary Sources Peer-reviewed

Oops!

An unknown error has occurred. Please click the button below to reload the page. If the problem persists, please try again in a little while.